Ameye G - Search Results

1

The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.

Duhoux FP, Auger N, De Wilde S, Wittnebel S, Ameye G, Bahloula K, Van den Berg C, Libouton JM, Saussoy P, Grand FH, Demoulin JB, Poirel HA. Duhoux FP, et al. Among authors: ameye g. Leuk Res. 2011 Jul;35(7):e114-7. doi: 10.1016/j.leukres.2011.02.011. Epub 2011 Mar 9. Leuk Res. 2011. PMID: 21388681 No abstract available.

2

The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias.

Duhoux FP, Ameye G, Libouton JM, Bahloula K, Iossifidis S, Chantrain CF, Demoulin JB, Poirel HA. Duhoux FP, et al. Among authors: ameye g. Leuk Res. 2011 Sep;35(9):e171-2. doi: 10.1016/j.leukres.2011.04.022. Epub 2011 May 26. Leuk Res. 2011. PMID: 21620472 No abstract available.

3

Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.

Duhoux FP, De Wilde S, Ameye G, Bahloula K, Medves S, Légé G, Libouton JM, Demoulin JB, A Poirel H. Duhoux FP, et al. Among authors: ameye g. Leuk Res. 2011 Mar;35(3):e18-20. doi: 10.1016/j.leukres.2010.09.024. Epub 2010 Oct 25. Leuk Res. 2011. PMID: 20980053 No abstract available.

4

Novel head-to-head gene fusion of MLL with ZC3H13 in a JAK2 V617F-positive patient with essential thrombocythemia without blast cells.

Duhoux FP, Ameye G, Lambert C, Herman M, Iossifidis S, Constantinescu SN, Libouton JM, Demoulin JB, Poirel HA. Duhoux FP, et al. Among authors: ameye g. Leuk Res. 2012 Jan;36(1):e27-30. doi: 10.1016/j.leukres.2011.09.003. Epub 2011 Oct 1. Leuk Res. 2012. PMID: 21962339 No abstract available.

5

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.

Medves S, Duhoux FP, Ferrant A, Toffalini F, Ameye G, Libouton JM, Poirel HA, Demoulin JB. Medves S, et al. Among authors: ameye g. Leukemia. 2010 May;24(5):1052-5. doi: 10.1038/leu.2010.13. Epub 2010 Feb 18. Leukemia. 2010. PMID: 20164854 No abstract available.

6

PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.

Duhoux FP, Ameye G, Montano-Almendras CP, Bahloula K, Mozziconacci MJ, Laibe S, Wlodarska I, Michaux L, Talmant P, Richebourg S, Lippert E, Speleman F, Herens C, Struski S, Raynaud S, Auger N, Nadal N, Rack K, Mugneret F, Tigaud I, Lafage M, Taviaux S, Roche-Lestienne C, Latinne D, Libouton JM, Demoulin JB, Poirel HA; Groupe Francophone de Cytogénétique Hématologique (GFCH); Belgian Cytogenetic Group for Haematology and Oncology (BCG-HO). Duhoux FP, et al. Among authors: ameye g. Br J Haematol. 2012 Jan;156(1):76-88. doi: 10.1111/j.1365-2141.2011.08918.x. Epub 2011 Nov 3. Br J Haematol. 2012. PMID: 22050763 Free article.

7

Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies.

Dheur MS, Poirel HA, Ameye G, Tilman G, Saussoy P, Defour JP, Camboni A, Van Den Neste E, Coulie PG, van Baren N. Dheur MS, et al. Among authors: ameye g. Leuk Lymphoma. 2019 Apr;60(4):1043-1052. doi: 10.1080/10428194.2018.1508663. Epub 2018 Oct 2. Leuk Lymphoma. 2019. PMID: 30277098

8

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Duhoux FP, Ameye G, Lambot V, Herens C, Lambert F, Raynaud S, Wlodarska I, Michaux L, Roche-Lestienne C, Labis E, Taviaux S, Chapiro E, Nguyen-Khac F, Struski S, Dobbelstein S, Dastugue N, Lippert E, Speleman F, Van Roy N, De Weer A, Rack K, Talmant P, Richebourg S, Mugneret F, Tigaud I, Mozziconacci MJ, Laibe S, Nadal N, Terré C, Libouton JM, Decottignies A, Vikkula M, Poirel HA; Groupe Francophone de Cytogénétique Hématologique (GFCH); Belgian Cytogenetic Group for Hematology and Oncology (BCG-HO). Duhoux FP, et al. Among authors: ameye g. PLoS One. 2011;6(10):e26311. doi: 10.1371/journal.pone.0026311. Epub 2011 Oct 21. PLoS One. 2011. PMID: 22039459 Free PMC article.

9

Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.

Havelange V, Ameye G, Théate I, Callet-Bauchu E, Mugneret F, Michaux L, Dastugue N, Penther D, Barin C, Collonge-Rame MA, Baranger L, Terré C, Nadal N, Lippert E, Laï JL, Cabrol C, Tigaud I, Herens C, Hagemeijer A, Raphael M, Libouton JM, Poirel HA; GFCH (Groupe Francophone de Cytogénétique Hématologique). Havelange V, et al. Among authors: ameye g. Genes Chromosomes Cancer. 2013 Jan;52(1):81-92. doi: 10.1002/gcc.22008. Epub 2012 Sep 25. Genes Chromosomes Cancer. 2013. PMID: 23012230

10

Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.

Put N, Konings P, Rack K, Jamar M, Van Roy N, Libouton JM, Vannuffel P, Sartenaer D, Ameye G, Speleman F, Herens C, Poirel HA, Moreau Y, Hagemeijer A, Vandenberghe P, Michaux L; Belgian Cytogenetic Group for Hemato-Oncology (BCGHO). Put N, et al. Among authors: ameye g. Genes Chromosomes Cancer. 2009 Oct;48(10):843-53. doi: 10.1002/gcc.20691. Genes Chromosomes Cancer. 2009. PMID: 19582829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters